Hidenobu Ishii

Kurume University — Japan

Medicine · Health Sciences

17h-index1.5kcitations84works0.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(41), Lung Cancer Research Studies(26), Lung Cancer Diagnosis and Treatment(18), Cancer Immunotherapy and Biomarkers(16), Colorectal Cancer Treatments and Studies(14)

Publications84 total

Biomarker study on pneumonitis in durvalumab maintenance therapy after chemoradiotherapy for stage III non-small cell lung cancer
BMC Cancer·2025Open Access
Cemiplimab in Japanese patients with advanced non-small cell lung cancer
Japanese Journal of Clinical Oncology·2025Open Access
Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for TTF-1 negative advanced nonsquamous non–small cell lung cancer: A multicenter, single-arm phase 2 trial (F1NE TUNE, LOGiK 2102)
European Journal of Cancer·2025Open Access
Platinum plus etoposide with durvalumab for extensive-stage small-cell lung cancer with untreated brain metastases: a multicenter, single-arm phase II trial (LOGiK2001, SPEED)
ESMO Open·2025Open Access
Turtle Study: A Phase 2 Study of Durvalumab Plus Carboplatin and Etoposide in Elderly Patients With Extensive-Stage SCLC (LOGiK 2003)
JTO Clinical and Research Reports·2025Open Access
The Impact of Adverse Events in Transbronchial Lung Cryobiopsy on Histopathological Diagnosis
Journal of Clinical Medicine·2025· 1 citedOpen Access
Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529)
Radiation Oncology·2025· 2 citedOpen Access
Study protocol of an open-label prospective phase II study of Durvalumab plus Carboplatin and Etoposide in advanced large cell neuroendocrine carcinoma of the lung (LOGIK2401: NECTAR study)
Cancer Treatment and Research Communications·2025Open Access
Atezolizumab with Carboplatin Plus Nab-Paclitaxel Combination Therapy for TTF-1 Negative Advanced Nonsquamous Non–Small Cell Lung Cancer: A Multicenter, Single-Arm Phase 2 Trial (F1NE TUNE, LOGiK 2102)
SSRN Electronic Journal·2025Open Access
Single-arm Multicenter Phase II Study on Aggressive Local Consolidative Therapy in Combination With Systemic Chemotherapy for Stage IV Non- small Cell Lung Carcinoma With Oligometastases: CURE-OLIGO (TORG1529)
2024Open Access
A phase <scp>II</scp> study of weekly carboplatin and concurrent radiotherapy in older adults with locally advanced non‐small cell lung cancer (<scp>LOGIK1902</scp>)
Thoracic Cancer·2024· 2 citedOpen Access
Thoracic Angiosarcoma Arising from Chronic Tuberculous Pyothorax
Internal Medicine·2024· 2 citedOpen Access
Obesity may be a risk factor for transbronchial lung cryobiopsy-related adverse events in Japanese patients with interstitial lung disease
Respiratory Investigation·2023· 1 cited
MO57-1 A phase II study of chemotherapy plus local therapy for non-small cell lung cancer with oligometastases: TORG1529
Annals of Oncology·2023Open Access
Reconsidering the Cutoff Value for Sensitive and Refractory Relapses in Extensive-Stage SCLC in the Era of Immunotherapy
Journal of Thoracic Oncology·2023· 13 citedOpen Access
Reconsidering the cutoff between sensitive and refractory relapses in extensive-stage small cell lung cancer in the era of immunotherapy.
Journal of Clinical Oncology·2023
Proton Beam Therapy as a Curative Treatment for a Young Case of Unresectable Tracheal Adenoid Cystic Carcinoma
Internal Medicine·2023Open Access
Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial
BMC Cancer·2023· 8 citedOpen Access
Forthcoming Phase II Study of Durvalumab (MEDI4736) Plus Chemotherapy for Small Cell Lung Cancer with Brain Metastases
Cancer Management and Research·2022· 5 citedOpen Access
Phase <scp>II</scp> study of durvalumab (<scp>MEDI</scp> 4736) plus carboplatin and etoposide in elderly patients with extensive stage small cell lung cancer: Study protocol of turtle study (<scp>LOGIK</scp> 2003)
Thoracic Cancer·2022· 5 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Koichi Azuma(37), Tomoaki Hoshino(31), Takaaki Tokito(30), Kazuhiko Yamada(28), Norikazu Matsuo(18), Takashi Kinoshita(13), Akihiko Kawahara(12), Yoshiko Naito(8), Jun Akiba(7), Isamu Okamoto(6), Hiroaki Takeoka(5), Masayoshi Kage(4), Yohei Imamura(4), Kazuko Sakai(4), Kazuto Nishio(4), Kazuhisa Takahashi(4), Masao Ichiki(4), Masayuki Nakamura(4), Fabrice Barlési(3), Johan Vansteenkiste(3)